Diphtheria, once a global scourge, had been relegated to the margins of public health concern in much of the world thanks to decades of successful vaccination campaigns. Yet, in 2025, the disease is making a troubling...
The global resurgence of measles represents a critical public health challenge, threatening decades of progress toward elimination. This review synthesizes recent research on measles epidemiology, prediction modeling...
Despite over five decades of the availability of safe and efficacious vaccines, the global failure to eliminate measles is not a consequence of scientific uncertainty, vaccine inefficacy, or insurmountable logistical...
The tick-borne encephalitis (TBE) vaccine was first licensed in 1976, at a time when the disease was, and remains, comparatively rare incidence in Austria is approximately 7 cases per 100,000 population. Because of this...
The abrupt removal of all 17 members of the Advisory Committee on Immunization Practices (ACIP) by the U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has triggered intense backlash from the...
The below review of recent pertussis research articles reiterates well-characterized pertussis dynamics but leave critical questions unanswered: Can mucosal vaccines outperform natural infection in blocking transmission...
At the top of this week’s vaccine news, Secretary Robert F. Kennedy Jr. has taken the unprecedented step of dismissing all current members of the Advisory Committee on Immunization Practices (ACIP, The USA-NITAG). This...
The world stands at a critical juncture in the fight against polio. Since the launch of the Global Polio Eradication Initiative (GPEI) in 1988, polio cases have been reduced by over 99.9%, saving millions from paralysis...
Moderna, once celebrated for its rapid development of a lifesaving COVID-19 vaccine during the initial Trump administration, now finds itself navigating a dramatically changed landscape as the U.S. government tightens...
A study published by Gontu et al. offers a powerful proof-of-concept for a next-generation mRNA vaccine platform that combines dose efficiency, cross-variant protection, and modular design. If validated in clinical...